Sherry Niessen

机构：Mirati Therapeutics (United States)

发表论文 108 篇 · 总被引 9493 次 · h-index 52

代表论文

• Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor (2021 · Cancer Cell · 被引 194)
• Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity (2023 · Cell · 被引 182)
• Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer (2021 · Journal of Medicinal Chemistry · 被引 121)
• Reversible lysine-targeted probes reveal residence time-based kinase selectivity (2022 · Nature Chemical Biology · 被引 104)
• Proteome-wide Map of Targets of T790M-EGFR-Directed Covalent Inhibitors (2017 · Cell chemical biology · 被引 103)
• Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1 (2020 · Journal of Biological Chemistry · 被引 96)